MYCB1
Live / Registered — Registered (as of 22 Oct 2019)
What this means for you
Registered since 22 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88233797
- Registration number
- 5888892
- Mark type
- Design + words
- Filed
- 18 Dec 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 22 Oct 2019
- Attorney of record
- Alexander Lazouski
Goods and services
- Class 005 — Pharmaceuticals: Nutraceutical products for use as dietary supplements or for therapeutic purposes; Nutritional supplements; Dietetic foods adapted for medical use; Biotechnological preparations for medical use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, heart disease, cancer prevention and treatment, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Biotechnological services, namely, research and consultancy in the field of biotechnology; Development of biotechnological products
Owner
- MYCB1 GROUP B.V., AMSTERDAM, NL
- CB1 B.V., Amsterdam, NL
- CB1 B.V., Amsterdam, NL
- CB1 B.V., Amsterdam, NL
Prosecution history
- 22 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Oct 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2019 — PUBLISHED FOR OPPOSITION
- 17 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jul 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jul 2019 — EXAMINER'S AMENDMENT ENTERED
- 01 Jul 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Jul 2019 — EXAMINERS AMENDMENT E-MAILED
- 01 Jul 2019 — EXAMINERS AMENDMENT -WRITTEN
- 07 Jun 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jun 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Jun 2019 — ASSIGNED TO LIE
- 30 May 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED